维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Saphner"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer显示文摘	Tormey DC Gray R	1991	J Clin Oncol1991，9，2：	1
2	Annual hazard rates of recurrence tor breast Cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
3	A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer 显示文摘	Miller KD Saphner TJ Waterhouse DM	2004	Clin Cancer Res2004，10，：	1
4	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，：	1
5	Annual hazard rates of recmTence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
6	Annual hazard rates of recurrencefor breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
7	The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer显示文摘	Saphner T Triest-Robertson S Li H	2009	Cancer2009，115，14：	1
8	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	SAPHNER T TORMEY DC GRAY R	1996	J Clin Oncol1996，14，10：	1
9	The Associ- ation of nonalcoholic stcatohepatitis and tamoxifen in patients with breast cancer显示文摘	SAPHNER T TRIEST ROBERTSON S LI H	2009	Cancer2009，115，14：	1
10	Theassociation of nonalcoholic steatohepatitis and tamoxifen inpatients with breast cancer显示文摘	Saphner T Triest-Robertson S Li H	2009	Cancer2009，115，14：	1
11	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R		0，，：	1
12	A randomized phase I1 feasibility trial of BMS - 275291 in patients with early stage breast cancer 显示文摘	Miller KD Saphner TJ Waterhouse DM	2004	Clin Cancer Res2004，10，6：	1
13	Annual hazard rates ofrecurrence for breast cancer after primary therapy显示文摘	SAPHNER T TORMEY D C GRAY R	1996	J Clin On-col1996，14，10：	1
14	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，，：	1
15	Annual hazard rates of recurrence for breast cancer after primary therapy 显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
16	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
17	The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer显示文摘	Saphner T Triest-Robertson S Li H	2009	Cancer2009，115，14：	1
18	Annual hazard rates of recurrence for breast cancer after primary therapy显示文摘	Saphner T Tormey DC Gray R	1996	J Clin Oncol1996，14，10：	1
19	The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer显示文摘	Saphner T Triest-Robertson S Li H	2009	Cancer2009，115，14：	1
20	A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast caneer显示文摘	Miller KD Saphner TJ Waterhouse DM	2004	Clin Cancer Res2004，10，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示